covid-19 vaccine (inactivated, adjuvanted) valneva
valneva austria gmbh - covid-19 vaccine (inactivated, adjuvanted, adsorbed) - covid-19 virus infection - bóluefni - covid-19 vaccine (inactivated, adjuvanted) valneva is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 18 to 50 years of age. the use of this vaccine should be in accordance with official recommendations.
kdpc kanolacide spray adjuvant
kd plant care pty ltd - canola oil - emulsifiable concentrate - canola oil oil-plant extract active 865.0 g/l - adjuvant - adjuvant | boomspray | broadacre | knapsack application | tool | tree | vegetable | bulb vegetable | cole vegetable | cucurbit | - carrier - anti-evaporant | reduce spray drift | spreading agent | wetting agent (use as directed) | adjuvant | evaporant | herbicide application | improve penetrating properties | insecticide application | wetter
imtrade ammonium sulphate herbicide adjuvant
imtrade australia pty ltd - ammonium sulphate - granular formulation - ammonium sulphate ammonium active 980.0 g/kg - adjuvant - adjuvant | herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agen - tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank
assert ammonium sulphate - spray adjuvant
victorian chemical company proprietary limited - ammonium sulphate - aqueous concentrate - ammonium sulphate ammonium active 417.0 g/l - adjuvant - adjuvant - tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank
farmoz amplify spray tank adjuvant
adama australia pty limited - mineral oil - emulsifiable concentrate - mineral oil petroleum derivative-oil other 432.0 g/l - adjuvant - adjuvant - selective herbicides | tank mixing | additive | agricultural chemical | herbicide | in crop use | minimise antagonism | spray tank
nexus spray adjuvant
victorian chemical company proprietary limited - canola oil - emulsifiable concentrate - canola oil oil-plant extract active 865.0 g/l - adjuvant - adjuvant | boomspray | broadacre | knapsack application | tool | tree | vegetable | bulb vegetable | cole vegetable | cucurbit | - carrier - anti-evaporant | reduce spray drift | spreading agent | wetting agent (use as directed) | adjuvant | evaporant | herbicide application | improve penetrating properties | insecticide application | wetter
grow green xtend plant oil adjuvant
grow green pty ltd - vegetable oil (emulsifiable) - emulsifiable concentrate - vegetable oil (emulsifiable) oil-plant extract active 832.0 g/l - adjuvant - adjuvant - spreader spray (refer to directions)
amway all-purpose spray adjuvant
amway of australia - coconut diethanolamide - cocomide diethanolamide; c12-c15 alcohol ethoxylate - liquid concentrate - coconut diethanolamide - cocomide diethanolamide emulsifiers & surfactants active 80.0 g/l; c12-c15 alcohol ethoxylate emulsifiers & surfactants active 125.0 g/l - adjuvant - adjuvant - wetting agent (use as directed) | improve penetrating properties
prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals
glaxosmithkline biologicals s.a. - split influenza virus, inactivated, containing antigen: a/vietnam/1194/2004 (h5n1) like strain used (nibrg-14) - influenza, human; immunization; disease outbreaks - vaccines - active immunisation against h5n1 subtype of influenza a virus.this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared from a/vietnam/1194/2004 nibrg-14 (h5n1) (see section 5.1).prepandemic influenza vaccine (h5n1) (split virion, inactivated, adjuvanted) glaxosmithkline biologicals 3.75 µg should be used in accordance with official guidance.
prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,